Link Pharma Chem Limited (LINKPH.BO)
INR 41.7
(-2.56%)
INR 41.7
(-2.56%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.18 Million | -17.06 Million | -12.59 Million | 48.44 Million | 29.54 Million | 13.64 Million |
| Net Income | -13.62 Million | 8.86 Million | 26.21 Million | 16.78 Million | 14.41 Million | 9.3 Million |
| Depreciation & Amortization | 10.34 Million | 9.22 Million | 9.27 Million | 8.74 Million | 9.27 Million | 8.94 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 9.32 Million | -44.33 Million | -41.64 Million | 21.8 Million | -6.39 Million | -6.33 Million |
| Other non-cash items | 10.9 Million | 9.17 Million | -6.44 Million | 1.11 Million | 12.24 Million | 1.72 Million |
| Investing Cash Flow | 3.23 Million | -750 Thousand | -49.67 Million | -21.62 Million | -16.61 Million | -9.61 Million |
| Investments in PPE | -9.5 Million | -8.92 Million | -11.55 Million | -18.05 Million | -17.12 Million | -8.79 Million |
| Acquisitions | 1.2 Million | - | 4.11 Million | 1.02 Million | 325 Thousand | 74.99 Thousand |
| Investment purchases | -2.87 Million | -34.19 Million | -48.39 Million | -4.52 Million | -524.57 Thousand | -888.72 Thousand |
| Sales/Maturities of investments | 14.41 Million | 40.88 Million | 5.16 Million | - | - | - |
| Other Investing Activities | 13.55 Million | 1.48 Million | 1.01 Million | -66 Thousand | 712.92 Thousand | -3975.00 |
| Financing Cash Flow | 4.65 Million | 16.07 Million | 22.72 Million | -3.3 Million | 5.52 Million | -4.56 Million |
| Debt repayment | -4.65 Million | -13.65 Million | -8.6 Million | -13.87 Million | -15.46 Million | -711.95 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 11.56 Million | 29.73 Million | 31.33 Million | 10.57 Million | 20.99 Million | -3.85 Million |
| Accounts receivables | -15.77 Million | 13.2 Million | 1.86 Million | -5.57 Million | -19.5 Million | 1.41 Million |
| Accounts payables | -49.09 Million | 6.45 Million | -17.12 Million | 48.24 Million | -5.56 Million | -531.03 Thousand |
| Inventory | 60.42 Million | -74.92 Million | -22.6 Million | -8.65 Million | 12.37 Million | -2.35 Million |
| Other working capital | 13.76 Million | 10.94 Million | -3.77 Million | -12.2 Million | 6.3 Million | -4.86 Million |
| Cash at beginning of period | 939 Thousand | 2.67 Million | 42.22 Million | 18.7 Million | 247.15 Thousand | 785.76 Thousand |
| Cash at end of period | 894 Thousand | 939 Thousand | 2.67 Million | 42.22 Million | 18.7 Million | 247.15 Thousand |
| Capital Expenditure | -9.5 Million | -8.92 Million | -11.55 Million | -18.05 Million | -17.12 Million | -8.79 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -45 Thousand | -1.74 Million | -39.54 Million | 23.51 Million | 18.45 Million | -538.61 Thousand |
| Free Cash Flow | -17.68 Million | -25.99 Million | -24.14 Million | 30.38 Million | 12.41 Million | 4.84 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.62 Million | 2.6 Million | 2.21 Million | -10.21 Million | -8.22 Million | 8.86 Million |
| Depreciation & Amortization | 10.34 Million | - | 2.66 Million | 2.61 Million | 2.57 Million | 9.22 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 9.32 Million | - | - | - | - | -44.33 Million |
| Other non-cash items | 10.9 Million | -2.6 Million | -2.21 Million | 10.21 Million | 8.22 Million | 9.17 Million |
| Investing Cash Flow | 3.23 Million | - | - | - | - | -750 Thousand |
| Investments in PPE | -9.5 Million | - | - | - | - | -8.92 Million |
| Acquisitions | 1.2 Million | - | - | - | - | - |
| Investment purchases | -2.87 Million | - | - | - | - | -34.19 Million |
| Sales/Maturities of investments | 14.41 Million | - | - | - | - | 40.88 Million |
| Other Investing Activities | 13.55 Million | - | - | - | - | 1.48 Million |
| Financing Cash Flow | 4.65 Million | - | - | - | - | 16.07 Million |
| Debt repayment | -4.65 Million | - | - | - | - | -13.65 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 11.56 Million | - | - | - | - | 29.73 Million |
| Accounts receivables | -15.77 Million | - | - | - | - | 13.2 Million |
| Accounts payables | -49.09 Million | - | - | - | - | 6.45 Million |
| Inventory | 60.42 Million | - | - | - | - | -74.92 Million |
| Other working capital | 13.76 Million | - | - | - | - | 10.94 Million |
| Cash at beginning of period | 939 Thousand | - | 20.93 Million | 31.14 Million | 939 Thousand | 2.67 Million |
| Cash at end of period | 894 Thousand | - | 2.21 Million | 20.93 Million | -8.22 Million | 939 Thousand |
| Capital Expenditure | -9.5 Million | - | - | - | - | -8.92 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -45 Thousand | - | -18.72 Million | -10.21 Million | -9.16 Million | -1.74 Million |
| Free Cash Flow | -17.68 Million | - | 2.21 Million | -10.21 Million | -8.22 Million | -25.99 Million |
DICIND
CNTRF
SRS
BLBX
PAOG
NVLPF